TG Therapeutics | TGTX - Equity Capital And Reserves



TG Therapeutics reported $276.43M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
AbbVie USD 1.46B 1.86B Mar/2025
Alaunos Therapeutics USD 2.06M 661K Dec/2024
Amgen USD 7.43B 1.22B Jun/2025
Ardelyx USD 139.53M 33.76M Jun/2025
Arrowhead Research USD 522.31M 161.91M Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
Corcept Therapeutics USD 635.79M 47.49M Jun/2025
Dynavax Technologies USD 494.16M 36.78M Jun/2025
Gilead Sciences USD 19.67B 596M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Novartis USD 42.05B 3.6B Jun/2025
PTC Therapeutics USD -206546000 20.79M Jun/2025
Regeneron Pharmaceuticals USD 29.94B 551.3M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
TG Therapeutics USD 276.43M 39.14M Jun/2025
Vertex Pharmaceuticals USD 17.18B 679.1M Jun/2025